Robert Dillard

Robert Dillard is a contributing writer with Cancer Nursing Today and its parent company, Mashup Media LLC. As a medical writer and editor, Mr. Dillard is experienced at producing high-quality clinical articles, blog articles, news releases, whitepapers, and a wide array of educational and promotional content pieces. Mr. Dillard has been writing in the health care space for over seven years and previously served as a public relations specialist, a field in which he holds a Bachelor of Arts degree from Rowan University. He lives in Manalapan, NJ, with his son.

Articles by Robert Dillard

Universal Extracellular Vesicles and PD-L1+ Extracellular Vesicles as Biomarkers for DLBCL

Robert Dillard

Lymphoma | November 16, 2021

Universal extracellular vesicles (EVs) and PD-L1-positive extracellular vesicles may be viable biomarkers for predicting ...

Small Extracellular Vesicles Used for Monitoring DLBCL

Robert Dillard

Lymphoma | November 16, 2021

A study published in the British Journal of Cancer found that analyzing small extracellular vesicles (sEVs) could be useful ...

International Prognostic Index-Based Immune Prognostic Model for DLBCL

Robert Dillard

Lymphoma | November 16, 2021

Researchers of a study developed an International Prognostic Index-based immune prognostic model (IPI-IPM) that yields robust ...

Diagnosing and Staging DLBCL Using Label-Free Surface-Enhanced Raman Spectroscopy

Robert Dillard

Lymphoma | November 16, 2021

A study shows that label-free surface-enhanced Raman spectroscopy (SERS) in combination with descriptive analysis may ...

Intratumoral T-Cell Receptor Repertoire is Predictive of Improved Survival after R-CHOP for DLBCL

Robert Dillard

Lymphoma | November 12, 2021

A study sought to explore the impact of intratumoral T-cell receptor (TCR) repertoire on interim positron emission tomography ...

Deciphering Genes Associated with DLBCL Lymphomatous Effusions

Robert Dillard

Lymphoma | November 2, 2021

Previous studies have shown that lymphomatous effusions in patients with diffuse large B-cell lymphoma (DLBCL) are linked ...

Artesunate Effective in Treating DLBCL

Robert Dillard

Lymphoma | November 2, 2021

The results of a study indicate that artesunate (ART), a water-soluble derivative of artemisinin, may help in fighting ...

Revised International Prognostic Index and Genetic Alterations Are Associated with Early Failure to R-CHOP in Patients with DLBCL

Robert Dillard

Lymphoma | November 2, 2021

A study assessed clinical biological features in relapsed or refractory diffuse large B-cell lymphoma (DLBCL) patients to ...

Assessing the Prognostic Value of Different Indices in Newly Diagnosed DLBCL

Robert Dillard

Lymphoma | November 2, 2021

A study which appeared in Annals of Palliative Medicine aimed to evaluate the prognostic significance of the advanced lung ...

Clinical Characteristics and Prognosis of Patients with Primary Bone DLBCL

Robert Dillard

Lymphoma | November 2, 2021

A study assessed clinical characteristics and prognosis among patients with primary bone diffuse large B-cell lymphoma ...

670 Madison Ave.

Manalapan, NJ 07726

Connect

Our Network

Blood Cancers Today

GU Oncology Now

Urban Health Today

About Us

Editorial Policy

© 2022 Mashup Media, LLC. All rights reserved.

Terms of Use | Privacy Policy